Jälgige meid
EE
EE

Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine.

Nutirakendus aitab luua kontakti arstide ja HIV positiivsete inimeste vahel. Nutirakendus aitab mugavalt organiseerida ravimite võtmise aegu, seadistada ainult Teile arusaadavad ja personaalseid meeldetuletusi, võimaldab saada arstilt tagasisidet ning panna aega vastuvõtule või analüüsidele.

Kõik uudised / September 2017

Arhiiv

✕
29 september 2017
11330
Centers for Disease Control joins consensus on HIV that ‘Undetectable = Untransmittable’

Centers for Disease Control joins consensus on HIV that ‘Undetectable = Untransmittable’

In a statement acknowledging National Gay Men’s HIV/AIDS Awareness Day Wednesday, the Centers for Disease Control and Prevention embraced a scientific consensus with profound impacts. “When antiretroviral therapy results in viral suppression, defined as less than 200 copies/ml ...
29 september 2017
8760
Sidibé starts thinking about putting everyone on treatment by 2030

Sidibé starts thinking about putting everyone on treatment by 2030

UNAIDS executive director Michel Sidibé can happily list the recent successes that the global community has scored against HIV/AIDS. And he can update you on progress of the 90-90-90 targets. “If we manage to continue and keep the same pace, we'll reach our goals in 90-90-90 ...
28 september 2017
10082
European Commission approves Symtuza

European Commission approves Symtuza

Janssen has announced that the European Commission has approved its darunavir-based single-tablet regimen, Symtuza, for the treatment of HIV-1 in adults and adolescents in Europe.
27 september 2017
10019
HIV diagnoses on the rise among older people in Europe

HIV diagnoses on the rise among older people in Europe

The study authors warn that health care workers need to consider the possibility of HIV infection in older people. Health care providers should also acknowledge that older people are sexually active but less likely to use condoms.
27 september 2017
10586
Coffee could halve death risk for patients with HIV-HCV co-infection

Coffee could halve death risk for patients with HIV-HCV co-infection

A wealth of studies have hailed coffee for its potential health benefits, but for patients infected with both HIV and hepatitis C virus, the rewards could be even greater; a new study suggests that drinking at least three cups of coffee per day could halve their risk of ...
25 september 2017
10028
Chicago Joins the “Getting to Zero” Effort to End HIV

Chicago Joins the “Getting to Zero” Effort to End HIV

The AIDS Foundation of Chicago notes that if PrEP uptake increases from 20 percent to 40 percent and viral suppression increases from 50 percent to 70 percent, the city will attain “functional zero”—a point where the epidemic can no longer sustain itself.
25 september 2017
9982
The new app for HIV patients

The new app for HIV patients

The app would allow patients to drop half of their visits to the doctor, and the pilot project is examining if the method guarantees the same quality of monitoring and if it is user-friendly and cost-efficient. Earlier studies have indicated that the digital follow-up system ...
22 september 2017
11085
New high-quality pill for HIV to be launched in low-and middle-income countries at reduced price

New high-quality pill for HIV to be launched in low-and middle-income countries at reduced price

New high-quality antiretroviral therapy to be launched in South Africa, Kenya and over 90 low-and middle-income countries at reduced price. For about $75, the governments in South Africa and Kenya will soon be able to treat an HIV-infected person for 1 year with a pill taken ...
21 september 2017
10581
Marathon training is safe for people with HIV

Marathon training is safe for people with HIV

Marathon run training is safe for people with HIV, investigators from Germany report. Training also had a number of beneficial effects, including a significant increase in CD4 cell count and improvements in cholesterol and blood pressure. «The main finding of our study was ...
21 september 2017
9549
Sanofi tests three-in-one antibody to treat or prevent HIV

Sanofi tests three-in-one antibody to treat or prevent HIV

A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV, following successful tests in monkeys. If all goes well, the three-in-one antibody could be used either as a long-acting treatment or ...
Kasutusmugavuse parendamiseks rakendab veebileht küpsiseid.
Lehel mis tahes nuppu klõpsates nõustute küpsiste kasutamisega.